CVS to Cover Lilly’s GLP-1 Medications, Expanding Access
CVS Health will broaden coverage for Lilly’s GLP-1 medications, including the new pill Foundayo and Zepbound injectio...
Understand the key aspects of points and cash back rewards. Equip yourself with knowledge to maximize your benefits.
28,655 articlesCVS Health will broaden coverage for Lilly’s GLP-1 medications, including the new pill Foundayo and Zepbound injectio...
Factory construction and investment are rising rapidly, fueling talk of a manufacturing renaissance. Yet a wide gap b...
A new manufacturing revival gains momentum, led by Atomic Industries and its CEO. The plan envisions a 100-year build...
Investors are watching Criteo's early 2026 results to gauge the ad-tech pioneer's progress in privacy-friendly target...
As investors digest Karyopharm's Q1 2026 earnings, this guide breaks down what to watch, how to interpret the numbers...
Latin American ETFs EWZ and EWW are leading a regional rally in 2026, powered by stronger commodity markets and a shi...
Two AI stock contenders show different paths for growth and profits. This guide explains how to read quarterly revenu...
Rivian unveils the R2 with a sub-$45k price target and near-term shipments, while Lucid battles cash burn and no 2026...
Two CoinDCX co-founders were arrested by Indian police amid a fraud probe. The company denies wrongdoing and blames i...
When market sentiment turns sour, investors watch a single metric for clues. This article breaks down what this stock...
A Tuesday rally put Tower Semiconductor in the spotlight as investors priced in capacity upgrades and stronger demand...
Global markets edge higher as AI spending sustains profits and optimism into the summer. Analysts say tech leadership...